Literature DB >> 14738900

Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria.

N W Brattig1.   

Abstract

Onchocerca volvulus is a tissue-invasive parasitic nematode causing skin and eye pathology in human onchocerciasis. The filariae habour abundant intracellular Wolbachia bacteria, now recognised as obligatory symbionts, and therefore emerging as a novel target for chemotherapy. Recent research demonstrates that both the filariae and endobacteria contribute to the pathogenesis of onchocerciasis, and molecules have been identified that promote inflammatory or counter-inflammatory immune mechanisms, divert the host's immune response or procure evasion of the parasite.

Entities:  

Mesh:

Year:  2004        PMID: 14738900     DOI: 10.1016/j.micinf.2003.11.003

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  54 in total

Review 1.  Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62.

Authors:  Helen S Goodridge; Gillian Stepek; William Harnett; Margaret M Harnett
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

2.  Protective immunity to the larval stages of onchocerca volvulus is dependent on Toll-like receptor 4.

Authors:  Laura A Kerepesi; Ofra Leon; Sarah Lustigman; David Abraham
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.

Authors:  Francesca Tamarozzi; Alice Halliday; Katrin Gentil; Achim Hoerauf; Eric Pearlman; Mark J Taylor
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Arbonematodes - nematode infections transmissible by arthropods: arbeitskreis blut, untergruppe «bewertung blutassoziierter krankheitserreger»*.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-01-07       Impact factor: 3.747

5.  The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.

Authors:  M M Harnett; A J Melendez; W Harnett
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

Review 6.  Activation and regulation of toll-like receptors (TLRs) by helminth parasites.

Authors:  Priyanka Goel Venugopal; Thomas B Nutman; Roshanak Tolouei Semnani
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

7.  Immunohistology of ectopic secondary lymph follicles in subcutaneous nodules from patients with hyperreactive onchocerciasis (sowda).

Authors:  Norbert W Brattig; Klara Tenner-Racz; Simone Korten; Achim Hoerauf; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2010-06-04       Impact factor: 2.289

8.  MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study.

Authors:  A S Winkler; K Friedrich; S Velicheti; J Dharsee; R König; A Nassri; M Meindl; A Kidunda; T H Müller; L Jilek-Aall; W Matuja; T Gotwald; E Schmutzhard
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

9.  Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.

Authors:  Benjamin L Makepeace; Siv Aina Jensen; Sandra J Laney; Charles K Nfon; Leo M Njongmeta; Vincent N Tanya; Steven A Williams; Albert E Bianco; Alexander J Trees
Journal:  PLoS Negl Trop Dis       Date:  2009-11-10

10.  Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.

Authors:  Tarik Attout; Achim Hoerauf; Gaëlle Dénécé; Alexander Yaw Debrah; Yeboah Marfo-Debrekyei; Michel Boussinesq; Samuel Wanji; Valérie Martinez; Sabine Mand; Ohene Adjei; Odile Bain; Sabine Specht; Coralie Martin
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.